Abstract
Attention deficit hyperactivity disorder (ADHD) has a complex aetiology although theories associated with disturbances in dopaminergic and noradrenergic activity are most commonly cited. The importance of these catecholamines in ADHD is supported by its effective treatment utilising stimulant and non-stimulant medications that modify their activity. Recently, there has been interest in oxidative and nitrosative stress (O&NS) in ADHD and its potential to contribute to this condition. In this article, research investigating O&NS in ADHD is reviewed and its impact on catecholaminergic activity and neurological structure is discussed. Lifestyle, environmental, psychological and nutritional influences on O&NS in people with ADHD are reviewed, and evidence for the therapeutic efficacy of antioxidant-related therapies is assessed. A selection of interventions with antioxidant mechanisms is presented as potential options for the treatment of ADHD. However, further research is required to help elucidate the role of O&NS and antioxidants for the prevention and management of ADHD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akhondzadeh S, Mohammadi MR, Khademi M (2004) Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry 4:9. doi:10.1186/1471-244X-4-9
Amin KA, Abdel Hameid H II, Abd Elsttar AH (2010) Effect of food azo dyes tartrazine and carmoisine on biochemical parameters related to renal, hepatic function and oxidative stress biomarkers in young male rats. Food Chem Toxicol 48:2994–2999. doi:10.1016/j.fct.2010.07.039
Andreazza AC, Kauer-Sant’anna M, Frey BN, Bond DJ, Kapczinski F, Young LT, Yatham LN (2008) Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 111:135–144. doi:10.1016/j.jad.2008.04.013
Archana E, Pai P, Prabhu BK, Shenoy RP, Prabhu K, Rao A (2012) Altered biochemical parameters in saliva of pediatric attention deficit hyperactivity disorder. Neurochem Res 37:330–334. doi:10.1007/s11064-011-0616-x
Arnold LE, DiSilvestro RA (2005) Zinc in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15:619–627. doi:10.1089/cap.2005.15.619
Arnold LE et al (2011) Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. J Child Adolesc Psychopharmacol 21:1–19. doi:10.1089/cap.2010.0073
Arns M, van der Heijden KB, Arnold LE, Kenemans JL (2013) Geographic variation in the prevalence of attention-deficit/hyperactivity disorder: the sunny perspective. Biol Psychiatry 74:585–590. doi:10.1016/j.biopsych.2013.02.010
Avshalumov MV, Chen BT, Koos T, Tepper JM, Rice ME (2005) Endogenous hydrogen peroxide regulates the excitability of midbrain dopamine neurons via ATP-sensitive potassium channels. J Neurosci 25:4222–4231. doi:10.1523/JNEUROSCI.4701-04.2005
Babcock T, Ornstein CS (2009) Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective. Postgrad Med 121:73–82. doi:10.3810/pgm.2009.05.2005
Bener A, Kamal M (2014) Predict attention deficit hyperactivity disorder? Evidence -based medicine. Glob J Health Sci 6:47–57. doi:10.5539/gjhs.v6n2p47
Berk M, Malhi GS, Gray LJ, Dean OM (2013a) The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 34:167–177. doi:10.1016/j.tips.2013.01.001
Berk M et al (2013b) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11:200. doi:10.1186/1741-7015-11-200
Bilici M et al (2004) Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 28:181–190. doi:10.1016/j.pnpbp.2003.09.034
Bloch MH, Qawasmi A (2011) Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 50:991–1000. doi:10.1016/j.jaac.2011.06.008
Boudjeltia KZ et al (2011) Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction and recovery in healthy young men. PLoS One 6:e28230. doi:10.1371/journal.pone.0028230
Brown NC, Andreazza AC, Young LT (2014) An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res. doi:10.1016/j.psychres.2014.04.005
Bulut M, Selek S, Gergerlioglu HS, Savas HA, Yilmaz HR, Yuce M, Ekici G (2007) Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci 32:435–438
Bulut M et al (2013) Lipid peroxidation markers in adult attention deficit hyperactivity disorder: new findings for oxidative stress. Psychiatry Res 209:638–642. doi:10.1016/j.psychres.2013.02.025
Buske-Kirschbaum A, Schmitt J, Plessow F, Romanos M, Weidinger S, Roessner V (2013) Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology 38:12–23. doi:10.1016/j.psyneuen.2012.09.017
Çelik VK, Erşan E, Erşan S, Bakır S, Dogan O (2013) Plasma catalase, glutathione-s-transferase and total antioxidant activity levels of children with attention deficit and hyperactivity disorder. Adv Biosci Biotechnol 04:183–187. doi:10.4236/abb.2013.42026
Cemek M, Büyükokuroğlu ME, Sertkaya F, Alpdağtaş S, Hazini A, Önül A, Göneş S (2014) Effects of food color additives on antioxidant functions and bioelement contents of liver, kidney and brain tissues in rats. J Food Nutr Res 2:686–691. doi:10.12691/jfnr-2-10-6
Ceylan MF, Sener S, Bayraktar AC, Kavutcu M (2010) Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 34:1491–1494. doi:10.1016/j.pnpbp.2010.08.010
Ceylan MF, Sener S, Bayraktar AC, Kavutcu M (2012) Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci 66:220–226. doi:10.1111/j.1440-1819.2012.02330.x
Chang Z, Lichtenstein P, D’Onofrio BM, Sjolander A, Larsson H (2014a) Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry 71:319–325. doi:10.1001/jamapsychiatry.2013.4174
Chang Z et al (2014b) Stimulant ADHD medication and risk for substance abuse. J Child Psychol Psychiatry 55:878–885. doi:10.1111/jcpp.12164
Chen MH et al (2014) Is atopy in early childhood a risk factor for ADHD and ASD? A longitudinal study. J Psychosom Res 77:316–321. doi:10.1016/j.jpsychores.2014.06.006
Cheng S, Maeda T, Yoichi S, Yamagata Z, Tomiwa K, Japan Children’s Study G (2010) Early television exposure and children’s behavioral and social outcomes at age 30 months. J Epidemiol. 20(Suppl 2):S482–S489. doi:10.2188/jea.JE20090179
Chovanova Z et al (2006) Effect of polyphenolic extract, pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radic Res 40:1003–1010. doi:10.1080/10715760600824902
Christakis DA, Zimmerman FJ, DiGiuseppe DL, McCarty CA (2004) Early television exposure and subsequent attentional problems in children. Pediatrics 113:708–713. doi:10.1016/j.jpeds.2004.08.034
Comim CM et al (2014) Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder. Acta Neuropsychiatr 26:96–103. doi:10.1017/neu.2013.35
Cöngöloğlu A, Türkbay T, Doruk A, Topal T, Savaşer A, Aydın A (2006) Long-term methylphenidate treatment causes increased superoxide dismutase activity and unchanged lipid peroxidation in rat brain. BCP 16:79–83
Cooper CE, Vollaard NB, Choueiri T, Wilson MT (2002) Exercise, free radicals and oxidative stress. Biochem Soc Trans 30:280–285. doi:10.1016/j.pnpbp.2010.05.004
Cortese S et al (2013) Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psychiatry 54:227–246. doi:10.1111/jcpp.12036
Dinan TG, Stanton C, Cryan JF (2013) Psychobiotics: a novel class of psychotropic. Biol Psychiatry 74:720–726. doi:10.1016/j.biopsych.2013.05.001
Durston S (2003) A review of the biological bases of ADHD: what have we learned from imaging studies? Ment Retard Dev Disabil Res Rev 9:184–195. doi:10.1002/mrdd.10079
Dvořáková M et al (2007) Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (Pycnogenol®). Nutr Neurosci 10:151–157. doi:10.1080/09513590701565443
El-Wahab HM, Moram GS (2013) Toxic effects of some synthetic food colorants and/or flavor additives on male rats. Toxicol Ind Health 29:224–232. doi:10.1177/0748233711433935
Emiliani FE, Sedlak TW, Sawa A (2014) Oxidative stress and schizophrenia: recent breakthroughs from an old story. Curr Opin Psychiatry. doi:10.1097/YCO.0000000000000054
Fayyad J et al (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409. doi:10.1192/bjp.bp.106.034389
Ferguson CJ (2011) The influence of television and video game use on attention and school problems: a multivariate analysis with other risk factors controlled. J Psychiatr Res 45:808–813. doi:10.1016/j.jpsychires.2010.11.010
Garcia RJ, Francis L, Dawood M, Lai ZW, Faraone SV, Perl A (2013) Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus. Arthritis Rheum 65:1313–1318. doi:10.1002/art.37893
Garnock-Jones KP, Keating GM (2009) Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs 11:203–226. doi:10.2165/00148581-200911030-00005
Goksugur SB, Tufan AE, Semiz M, Gunes C, Bekdas M, Tosun M, Demircioglu F (2014) Vitamin D status in children with attention-deficit–hyperactivity disorder. Pediatr Int 56:515–519. doi:10.1111/ped.12286
Gomes KM, Petronilho FC, Mantovani M, Garbelotto T, Boeck CR, Dal-Pizzol F, Quevedo J (2008) Antioxidant enzyme activities following acute or chronic methylphenidate treatment in young rats. Neurochem Res 33:1024–1027. doi:10.1007/s11064-007-9544-1
Gulec M, Ozkol H, Selvi Y, Tuluce Y, Aydin A, Besiroglu L, Ozdemir PG (2012) Oxidative stress in patients with primary insomnia. Prog Neuropsychopharmacol Biol Psychiatry 37:247–251. doi:10.1016/j.pnpbp.2012.02.011
Gungor S, Celiloglu OS, Ozcan OO, Raif SG, Selimoglu MA (2013) Frequency of celiac disease in attention-deficit/hyperactivity disorder. J Pediatr Gastroenterol Nutr 56:211–214. doi:10.1097/MPG.0b013e318272b7bc
Gunville CF, Mourani PM, Ginde AA (2013) The role of vitamin D in prevention and treatment of infection. Inflamm Allergy Drug Targets 12:239–245
Hariri M, Djazayery A, Djalali M, Saedisomeolia A, Rahimi A, Abdolahian E (2012) Effect of n-3 supplementation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit–hyperactivity disorder. Malays J Nutr 18:329–335
Hassan W, Silva CE, Mohammadzai IU, da Rocha JB, Landeira-Fernandez J (2014) Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions. Curr Neuropharmacol 12:120–139. doi:10.2174/1570159X11666131120232135
Hawkey E, Nigg JT (2014) Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev 34:496–505. doi:10.1016/j.cpr.2014.05.005
Heilskov Rytter MJ et al (2014) Diet in the treatment of ADHD in children-A systematic review of the literature. Nord J Psychiatry. doi:10.3109/08039488.2014.921933
Howard AL, Robinson M, Smith GJ, Ambrosini GL, Piek JP, Oddy WH (2011) ADHD is associated with a “Western” dietary pattern in adolescents. J Atten Disord 15:403–411. doi:10.1177/1087054710365990
Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71:171–186
Huang YS, Tsai MH (2011) Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge. CNS Drugs 25:539–554. doi:10.2165/11589380-000000000-00000
Hvolby A (2014) Associations of sleep disturbance with ADHD: implications for treatment. Atten Defic Hyperact Disord. doi:10.1007/s12402-014-0151-0
Ikonomidou C, Kaindl AM (2011) Neuronal death and oxidative stress in the developing brain. Antioxid Redox Signal 14:1535–1550. doi:10.1089/ars.2010.3581
Jain S, Banerjee BD, Ahmed RS, Arora VK, Mediratta PK (2013) Possible role of oxidative stress and brain derived neurotrophic factor in triazophos induced cognitive impairment in rats. Neurochem Res 38:2136–2147. doi:10.1007/s11064-013-1122-0
Joseph N, Zhang-James Y, Perl A, Faraone SV (2013) Oxidative stress and ADHD: a meta-analysis. J Atten Disord. doi:10.1177/1087054713510354
Joshi K et al (2006) Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD). Prostaglandins Leukot Essent Fatty Acids 74:17–21. doi:10.1016/j.plefa.2005.10.001
Karababa IF et al (2014) Homocysteine levels and oxidative stress parameters in patients with adult ADHD. J Atten Disord. doi:10.1177/1087054714538657
Keyes KM, Davey Smith G, Susser E (2014) Associations of prenatal maternal smoking with offspring hyperactivity: causal or confounded? Psychol Med 44:857–867. doi:10.1017/S0033291713000986
Kiss JP, Zsilla G, Vizi ES (2004) Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors. Neurochem Int 45:485–489. doi:10.1016/j.neuint.2003.11.004
Langberg JM, Becker SP (2012) Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder? Clin Child Fam Psychol Rev 15:215–233. doi:10.1007/s10567-012-0117-8
Leal G, Afonso PM, Salazar IL, Duarte CB (2014) Regulation of hippocampal synaptic plasticity by BDNF. Brain Res. doi:10.1016/j.brainres.2014.10.019
Lichtenstein P et al (2012) Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med 367:2006–2014. doi:10.1056/NEJMoa1203241
Lingineni RK, Biswas S, Ahmad N, Jackson BE, Bae S, Singh KP (2012) Factors associated with attention deficit/hyperactivity disorder among US children: results from a national survey. BMC Pediatr 12:50. doi:10.1186/1471-2431-12-50
Liu DY et al (2014) The physiology of BDNF and its relationship with ADHD. Mol Neurobiol. doi:10.1007/s12035-014-8956-6
Lopresti AL, Hood SD, Drummond PD (2013) A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. J Affect Disord 148:12–27. doi:10.1016/j.jad.2013.01.014
Lopresti AL, Maes M, Hood SD, Maker GL, Drummond PD (2014) Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord 167:368–375. doi:10.1016/j.jad.2014.06.001
Maes M, Galecki P, Chang YS, Berk M (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 35:676–692
Mao AR, Findling RL (2014) Comorbidities in adult attention-deficit/hyperactivity disorder: a practical guide to diagnosis in primary care. Postgrad Med 126:42–51. doi:10.3810/pgm.2014.09.2799
Martins MR, Reinke A, Petronilho FC, Gomes KM, Dal-Pizzol F, Quevedo J (2006) Methylphenidate treatment induces oxidative stress in young rat brain. Brain Res 1078:189–197. doi:10.1016/j.brainres.2006.01.004
Meiser J, Weindl D, Hiller K (2013) Complexity of dopamine metabolism. Cell Commun Signal 11:34. doi:10.1186/1478-811X-11-34
Miyazaki I, Asanuma M (2008) Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med Okayama 62:141–150
Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ (2003) Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 35:772–781
Niederhofer H (2011) Association of attention-deficit/hyperactivity disorder and celiac disease: a brief report. Prim Care Companion CNS Disord. doi:10.4088/PCC.10br01104
Niederhofer H, Pittschieler K (2006) A preliminary investigation of ADHD symptoms in persons with celiac disease. J Atten Disord. 10:200–204. doi:10.1177/1087054706292109
Nigg JT, Holton K (2014) Restriction and elimination diets in ADHD treatment. Child Adolesc Psychiatr Clin N Am. 23:937–953. doi:10.1016/j.chc.2014.05.010
Nijmeijer JS, Minderaa RB, Buitelaar JK, Mulligan A, Hartman CA, Hoekstra PJ (2008) Attention-deficit/hyperactivity disorder and social dysfunctioning. Clin Psychol Rev 28:692–708. doi:10.1016/j.cpr.2007.10.003
Oztop D, Altun H, Baskol G, Ozsoy S (2012) Oxidative stress in children with attention deficit hyperactivity disorder. Clin Biochem 45:745–748. doi:10.1016/j.clinbiochem.2012.03.027
Palta P, Samuel LJ, Miller ER 3rd, Szanton SL (2014) Depression and oxidative stress: results from a meta-analysis of observational studies. Psychosom Med 76:12–19. doi:10.1097/PSY.0000000000000009
Patra RC, Rautray AK, Swarup D (2011) Oxidative stress in lead and cadmium toxicity and its amelioration. Vet Med Int. 2011:457327. doi:10.4061/2011/457327
Pelsser LM, Frankena K, Toorman J, Savelkoul HF, Pereira RR, Buitelaar JK (2009) A randomised controlled trial into the effects of food on ADHD. Eur Child Adolesc Psychiatry 18:12–19. doi:10.1007/s00787-008-0695-7
Polanska K, Jurewicz J, Hanke W (2013) Review of current evidence on the impact of pesticides, polychlorinated biphenyls and selected metals on attention deficit/hyperactivity disorder in children. Int J Occup Med Environ Health 26:16–38. doi:10.2478/s13382-013-0073-7
Prasad AS (2014) Zinc: an antioxidant and anti-inflammatory agent: Role of zinc in degenerative disorders of aging. J Trace Elem Med Biol 28:364–371. doi:10.1016/j.jtemb.2014.07.019
Radak Z, Chung HY, Goto S (2008) Systemic adaptation to oxidative challenge induced by regular exercise. Free Radic Biol Med 44:153–159. doi:10.1016/j.freeradbiomed.2007.01.029
Rahman K (2007) Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2:219–236
Ruchi K, Anil Kumar S, Sunil G, Bashir A, Prabhat S (2011) Antioxidant activity in children with ADHD—a comparison in untreated and treated subjects with normal children. Med J Malays 10:31–35
Russo AJ (2010) Decreased serum Cu/Zn SOD associated with high copper in children with attention deficit hyperactivity disorder (ADHD). J Cent Nerv Syst Dis 2:9–14
Sankhwar ML et al (2013) Monocrotophos induced oxidative stress and alterations in brain dopamine and serotonin receptors in young rats. Toxicol Ind Health. doi:10.1177/0748233713500834
Scassellati C, Bonvicini C, Faraone SV, Gennarelli M (2012) Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. J Am Acad Child Adolesc Psychiatry 51(1003–1019):e1020. doi:10.1016/j.jaac.2012.08.015
Schmidt AJ et al (2010) Impact of psychostimulants and atomoxetine on the expression of 8-hydroxyguanine glycosylase 1 in human cells. J Neural Transm. 117:793–797. doi:10.1007/s00702-010-0408-5
Schmitt J, Buske-Kirschbaum A, Roessner V (2010) Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy 65:1506–1524. doi:10.1111/j.1398-9995.2010.02449.x
Schmitz F et al (2012a) Chronic methylphenidate administration alters antioxidant defenses and butyrylcholinesterase activity in blood of juvenile rats. Mol Cell Biochem 361:281–288. doi:10.1007/s11010-011-1113-x
Schmitz F, Scherer EB, Machado FR, da Cunha AA, Tagliari B, Netto CA, Wyse AT (2012b) Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats. Metab Brain Dis 27:605–612. doi:10.1007/s11011-012-9335-5
Sedky K, Bennett DS, Carvalho KS (2014) Attention deficit hyperactivity disorder and sleep disordered breathing in pediatric populations: a meta-analysis. Sleep Med Rev 18:349–356. doi:10.1016/j.smrv.2013.12.003
Seidman LJ, Valera EM, Makris N (2005) Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1263–1272. doi:10.1016/j.biopsych.2004.11.019
Selek S, Savas HA, Gergerlioglu HS, Bulut M, Yilmaz HR (2008) Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biol Psychol 79:256–259. doi:10.1016/j.biopsycho.2008.06.005
Selek S, Bulut M, Ocak AR, Kalenderoglu A, Savas HA (2012) Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications. J Psychiatr Res 46:451–455. doi:10.1016/j.jpsychires.2011.12.007
Shab-Bidar S, Neyestani TR, Djazayery A (2014) The interactive effect of improvement of vitamin D status and VDR FokI variants on oxidative stress in type 2 diabetic subjects: a randomized controlled trial. Eur J Clin Nutr. doi:10.1038/ejcn.2014.240
Sharma A, Couture J (2014) A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother 48:209–225. doi:10.1177/1060028013510699
Simon V, Czobor P, Balint S, Meszaros A, Bitter I (2009) Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 194:204–211. doi:10.1192/bjp.bp.107.048827
Sivaranjani N, Rao SV, Rajeev G (2013) Role of reactive oxygen species and antioxidants in atopic dermatitis. J Clin Diagn Res 7:2683–2685. doi:10.7860/JCDR/2013/6635.3732
Sonuga-Barke EJ et al (2013) Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 170:275–289. doi:10.1176/appi.ajp.2012.12070991
Spahis S, Vanasse M, Belanger SA, Ghadirian P, Grenier E, Levy E (2008) Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 79:47–53. doi:10.1016/j.plefa.2008.07.005
Sperner-Unterweger B, Kohl C, Fuchs D (2014) Immune changes and neurotransmitters: possible interactions in depression? Prog Neuropsychopharmacol Biol Psychiatry 48:268–276. doi:10.1016/j.pnpbp.2012.10.006
Stevens T, Mulsow M (2006) There is no meaningful relationship between television exposure and symptoms of attention-deficit/hyperactivity disorder. Pediatrics 117:665–672. doi:10.1542/peds.2005-0863
Stevenson J et al (2014) Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder–an appraisal of the evidence on efficacy and recommendations on the design of future studies. J Child Psychol Psychiatry 55:416–427. doi:10.1111/jcpp.12215
Tenenbaum S, Paull JC, Sparrow EP, Dodd DK, Green L (2002) An experimental comparison of Pycnogenol(R) and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD). J Atten Disord 6:49–60. doi:10.1177/108705470200600201
Trebaticka J et al (2006) Treatment of ADHD with French maritime pine bark extract. Pycnogenol. Eur Child Adolesc Psychiatry 15:329–335. doi:10.1007/s00787-006-0538-3
Tsang AH, Chung KK (2009) Oxidative and nitrosative stress in Parkinson’s disease. Biochim Biophys Acta 1792:643–650. doi:10.1016/j.bbadis.2008.12.006
Vargas HO et al (2013) Oxidative stress and inflammatory markers are associated with depression and nicotine dependence. Neurosci Lett 544:136–140. doi:10.1016/j.neulet.2013.03.059
Varol Tas F, Guvenir T, Tas G, Cakaloz B, Ormen M (2006) Nitric oxide levels in disruptive behavioral disorder. Neuropsychobiology 53:176–180. doi:10.1159/000093781
Visweswaran B, Krishnamoorthy G (2012) Oxidative stress by tartrazine in the testis of Wistar rats. IOSR J Pharm Biol Sci 2:44–49
Vojdani A, Vojdani C (2015) Immune reactivity to food coloring. Altern Ther Health Med 21(Suppl 1):52–62
Wegener G, Volke V, Rosenberg R (2000) Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol 130:575–580. doi:10.1038/sj.bjp.0703349
Wigal SB, Emmerson N, Gehricke JG, Galassetti P (2013) Exercise: applications to childhood ADHD. J Atten Disord 17:279–290. doi:10.1177/1087054712454192
Wilens TE, Morrison NR, Prince J (2011) An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother 11:1443–1465. doi:10.1586/ern.11.137
Wiles NJ, Northstone K, Emmett P, Lewis G (2009) ‘Junk food’ diet and childhood behavioural problems: results from the ALSPAC cohort. Eur J Clin Nutr 63:491–498. doi:10.1038/sj.ejcn.1602967
Willcutt EG (2012) The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 9:490–499. doi:10.1007/s13311-012-0135-8
Yen GC, Hsieh CL (1997) Antioxidant effects of dopamine and related compounds. Biosci Biotechnol Biochem 61:1646–1649
Yolton K, Cornelius M, Ornoy A, McGough J, Makris S, Schantz S (2014) Exposure to neurotoxicants and the development of attention deficit hyperactivity disorder and its related behaviors in childhood. Neurotoxicol Teratol 44:30–45. doi:10.1016/j.ntt.2014.05.003
Zeng C, Villar VA, Yu P, Zhou L, Jose PA (2009) Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens 31:156–178. doi:10.1080/10641960802621283
Zhang XY et al (2014) The interplay between BDNF and oxidative stress in chronic schizophrenia. Psychoneuroendocrinology 51C:201–208. doi:10.1016/j.psyneuen.2014.09.029
Zhu JL, Olsen J, Liew Z, Li J, Niclasen J, Obel C (2014) Parental smoking during pregnancy and ADHD in children: the Danish national birth cohort. Pediatrics 134:e382–e388. doi:10.1542/peds.2014-0213
Acknowledgments
The author would like to acknowledge the gracious assistance from Professor Peter Drummond for his helpful comments and feedback.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lopresti, A.L. Oxidative and nitrosative stress in ADHD: possible causes and the potential of antioxidant-targeted therapies. ADHD Atten Def Hyp Disord 7, 237–247 (2015). https://doi.org/10.1007/s12402-015-0170-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12402-015-0170-5